-
More Data on COVID-19 Vaccination and CancerStudies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.
by Anna Goshua
-
Chemobrain: It’s Not Your ImaginationScientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.
by Marci A. Landsmann
-
Immunotherapy Options for Breast CancerTwo immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
-
Cancer and Older Adults: Can Oncologists Do Better?Geriatric assessment reduces toxicity from treatment and improves quality of life in older adults with cancer.
by Marci A. Landsmann
-
Registries Report on COVID-19 and CancerData shed light on risk factors for death among people with cancer infected with the coronavirus.
by Kate Yandell
-
Using Leftover Cancer Drugs to Help OthersCancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.
by Jon Kelvey
-
Facing Cancer and a Pandemic at the Same TimeCancer patients and their families share stories of fear, love and uncertainty as they find new ways to support each other.
by Jen Tota McGivney
-
A Switch From Intravenous to Oral Chemo?Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.
by Ashley P. Taylor
-
Possible New Treatments for Patients With Metastatic HER2-Positive Breast CancerStudies presented at the San Antonio Breast Cancer Symposium show additional treatment options.
by Marci A. Landsmann
-
Learning the Language of ChemotherapyCancer patients often do not understand words their doctors use while talking about chemotherapy, but a new video series helps explain these terms.
by Jen Tota McGivney
A recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
Does Exercise Benefit Children With Cancer?New guidelines recommend children and adolescents with cancer get regular physical activity to mitigate side effects from treatment.
by Erin O’Donnell
Can the CYP2D6 Gene Affect Tamoxifen’s Effectiveness?A recent analysis examined whether CYP2D6 metabolism influences tamoxifen response. The answer isn’t entirely clear.
by Ashley P. Taylor
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
